Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 1;23(17):9992.
doi: 10.3390/ijms23179992.

Novel Triterpenic Acid-Benzotriazole Esters Act as Pro-Apoptotic Antimelanoma Agents

Affiliations

Novel Triterpenic Acid-Benzotriazole Esters Act as Pro-Apoptotic Antimelanoma Agents

Marius Mioc et al. Int J Mol Sci. .

Abstract

Pentacyclic triterpenes, such as betulinic, ursolic, and oleanolic acids are efficient and selective anticancer agents whose underlying mechanisms of action have been widely investigated. The introduction of N-bearing heterocycles (e.g., triazoles) into the structures of natural compounds (particularly pentacyclic triterpenes) has yielded semisynthetic derivatives with increased antiproliferative potential as opposed to unmodified starting compounds. In this work, we report the synthesis and biological assessment of benzotriazole esters of betulinic acid (BA), oleanolic acid (OA), and ursolic acid (UA) (compounds 1-3). The esters were obtained in moderate yields (28-42%). All three compounds showed dose-dependent reductions in cell viability against A375 melanoma cells and no cytotoxic effects against healthy human keratinocytes. The morphology analysis of treated cells showed characteristic apoptotic changes consisting of nuclear shrinkage, condensation, fragmentation, and cellular membrane disruption. rtPCR analysis reinforced the proapoptotic evidence, showing a reduction in anti-apoptotic Bcl-2 expression and upregulation of the pro-apoptotic Bax. High-resolution respirometry studies showed that all three compounds were able to significantly inhibit mitochondrial function. Molecular docking showed that compounds 1-3 showed an increase in binding affinity against Bcl-2 as opposed to BA, OA, and UA and similar binding patterns compared to known Bcl-2 inhibitors.

Keywords: 1-hydroxybenzotriazole esters; apoptosis; cytotoxicity; melanoma; molecular docking; rtPCR; triterpenic acids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Synthesis procedure of BA, OA, and UA-HOBt esters (13).
Figure 2
Figure 2
Cell viability of HaCaT and A375 cells after 24 h of treatment with 0.4, 2, 10, 25, and 50 μM of compounds 1 (A), 2 (B), and 3 (C), determined using the Alamar Blue assay. The results are expressed as cell viability percentage (%) normalized to control (100%). The data represent the mean values ± SD of three independent experiments performed in triplicate. The statistical differences vs. the control was determined using one-way ANOVA analysis followed by Tukey’s multiple comparisons post-test (* p < 0.05, ** p < 0.005 and *** p < 0.0001).
Figure 3
Figure 3
Representative images of the morphological aspects of HaCaT cells after treatment for 24 h with 1, 2 (25 μM), and 3 (50 μM). The scale bar was 100 μm.
Figure 4
Figure 4
Representative images of the morphological aspects of A375 cells after treatment for 24 h with 1, 2 (25 μM), and 3 (50 μM). The scale bar was 100 μm.
Figure 5
Figure 5
Nuclear staining using DAPI in HaCaT cells after treatment with 1, 2, and 3 (10, 25, and 50 μM) for 24 h. The pictures were captured 24 h post-treatment. The staurosporine solution (5 μM) was used as the positive control for apoptotic changes at the nuclear level. The yellow arrows represent signs of apoptosis, such as nuclear shrinkage, condensation, fragmentation, and cellular membrane disruption.
Figure 6
Figure 6
Nuclear staining using DAPI in A375 cells after treatment with 1, 2, and 3 (10, 25, and 50 μM) for 24 h. The pictures were captured 24 h post-treatment. The staurosporine solution (5 μM) was used as the positive control for apoptotic changes at the nuclear level. The yellow arrows represent signs of apoptosis, such as nuclear shrinkage, condensation, fragmentation, and cellular membrane disruption.
Figure 7
Figure 7
Relative fold change expression in mRNA of Bcl-2 and BAX in A375 cells after stimulation with 1, 2 (25 μM), and 3 (50 μM) for 24 h. The expressions were normalized to 18S and DMSO was used as the control. Data represent the mean values ± SD of three independent experiments. One-way ANOVA with Dunnett’s post-test was applied to determine the statistical differences in rapport with DMSO stimulated cells (* p < 0.05, ** p < 0.01, and *** p < 0.001).
Figure 8
Figure 8
Respiration of permeabilized immortalized human keratinocytes (HaCaT) and human melanoma cells (A375) following a 24 h stimulation with 25 μM 1. Data represent the mean ± SD of five individual experiments. Values with p < 0.05 were considered to have statistically significant differences (* p < 0.05, and *** p < 0.01). The respiratory parameters displayed represent the following: Routine—respiration of cells suspended in a substrate-free media, supported by endogenous ADP; State 2CI—mitochondrial respiration in basal conditions driven by CI, OXPHOSCI—active respiration dependent on CI substrates and exogenous ADP; OXPHOSCI+II—maximal active respiration driven by both CI and CII; State 4CI+II—basal respiration dependent on both CI and CII; ETSCI+II—maximal respiratory capacity of the electron transport system in the fully noncoupled state; ETSCII—electron transport system maximal capacity dependent only on CII.
Figure 9
Figure 9
Respiration of permeabilized immortalized human keratinocytes (HaCaT) and human melanoma cells (A375) following 24 h stimulation with 25 μM 2. Data represent the mean ± SD of five individual experiments. Values with p < 0.05 were considered to have statistically significant differences (* p < 0.05, ** p < 0.01, and *** p < 0.01). The respiratory parameters displayed represent the following: Routine—respiration of cells suspended in a substrate-free media, supported by endogenous ADP; State 2CI –mitochondrial respiration in basal conditions driven by CI, OXPHOSCI—active respiration dependent on CI substrates and exogenous ADP; OXPHOSCI+II—maximal active respiration driven by both CI and CII; State 4CI+II—basal respiration dependent on both CI and CII; ETSCI+II—maximal respiratory capacity of the electron transport system in the fully noncoupled state; ETSCII—electron transport system maximal capacity dependent only on CII.
Figure 10
Figure 10
Respiration of permeabilized immortalized human keratinocytes (HaCaT) and human melanoma cells (A375) following 24 h of stimulation with 50 μM 3. Data represent the mean ± SD of five individual experiments. Values with p < 0.05 were considered to have statistically significant differences (* p < 0.05, ** p < 0.01, and *** p < 0.01). The respiratory parameters displayed represent the following: Routine—respiration of cells suspended in a substrate-free media, supported by endogenous ADP; State 2CI—mitochondrial respiration in basal conditions driven by CI, OXPHOSCI—active respiration dependent on CI substrates and exogenous ADP; OXPHOSCI+II—maximal active respiration driven by both CI and CII; State 4CI+II—basal respiration dependent on both CI and CII; ETSCI+II—maximal respiratory capacity of the electron transport system in the fully noncoupled state; ETSCII—electron transport system maximal capacity dependent only on CII.
Figure 11
Figure 11
Structure of Bcl-2 (2W3L) in complex with compounds 1 (orange), 2 (blue), and 3 (green); HB interactions are depicted as green dotted lines, hydrophobic interactions as purple dotted lines, and electrostatic interactions as orange dotted lines; interacting amino acids are shown as dark gray sticks.

Similar articles

Cited by

References

    1. Hughes J., Rees S., Kalindjian S., Philpott K. Principles of early drug discovery. Br. J. Pharmacol. 2011;162:1239–1249. doi: 10.1111/j.1476-5381.2010.01127.x. - DOI - PMC - PubMed
    1. Ghante M.H., Jamkhande P.G. Role of Pentacyclic Triterpenoids in Chemoprevention and Anticancer Treatment: An Overview on Targets and Underling Mechanisms. J. Pharmacopunct. 2019;22:55–67. doi: 10.3831/KPI.201.22.007. - DOI - PMC - PubMed
    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Zhong Y., Liang N., Liu Y., Cheng M.-S. Recent progress on betulinic acid and its derivatives as antitumor agents: A mini review. Chin. J. Nat. Med. 2021;19:641–647. doi: 10.1016/S1875-5364(21)60097-3. - DOI - PubMed
    1. Ayeleso T., Matumba M., Mukwevho E. Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases. Molecules. 2017;22:1915. doi: 10.3390/molecules22111915. - DOI - PMC - PubMed